The Claim
The addition of suPAR, IL-6, and hsCRP measurements to the SCORE2-Diabetes risk model improves the model's ability to reclassify individuals into more accurate risk categories for mortality and major adverse cardiovascular events in adults with type 2 diabetes.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Adding three blood biomarkers—suPAR, IL-6, and hsCRP—to the SCORE2-Diabetes risk calculator improves how accurately it identifies which adults with type 2 diabetes are at higher or lower risk of death or serious heart events.
See the scientific wording
Adding suPAR, IL-6, and hsCRP measurements to the SCORE2-Diabetes risk model improves its ability to reclassify individuals into more accurate risk categories for mortality and major adverse cardiovascular events in adults with type 2 diabetes.
Persistent inflammation in the blood vessels damages the inner lining, causes fatty deposits to become unstable, and triggers clot formation, which leads to heart attacks, strokes, or death.
What the research says
1 studyDoctors can better predict which type 2 diabetes patients are at highest risk of heart problems or death by adding three simple blood tests for inflammation markers — suPAR, IL-6, and hsCRP — to their usual risk calculator. The study proved this makes the predictions more accurate.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.